Copeland Capital Management LLC Raises Holdings in Humana Inc. (NYSE:HUM)

Copeland Capital Management LLC lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 27.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 809 shares of the insurance provider’s stock after acquiring an additional 174 shares during the period. Copeland Capital Management LLC’s holdings in Humana were worth $256,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Swedbank AB lifted its holdings in shares of Humana by 3.0% during the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after purchasing an additional 3,085 shares during the period. Heritage Oak Wealth Advisors LLC acquired a new stake in shares of Humana during the second quarter worth about $3,456,000. Mandatum Life Insurance Co Ltd lifted its holdings in shares of Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock worth $4,434,000 after purchasing an additional 7,500 shares during the period. APG Asset Management US Inc. lifted its holdings in shares of Humana by 3.0% during the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after purchasing an additional 1,955 shares during the period. Finally, Sei Investments Co. lifted its holdings in shares of Humana by 0.4% during the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock worth $21,462,000 after purchasing an additional 264 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. UBS Group decreased their price target on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Cantor Fitzgerald reissued a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target for the company in a report on Tuesday, October 8th. Finally, Truist Financial decreased their price target on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus target price of $315.33.

Humana Stock Up 0.7 %

NYSE HUM opened at $262.30 on Wednesday. The business has a fifty day moving average price of $312.24 and a 200 day moving average price of $337.81. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $31.61 billion, a P/E ratio of 16.33, a P/E/G ratio of 1.91 and a beta of 0.50.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. During the same period in the prior year, the company earned $8.94 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Research analysts anticipate that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.35%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.